ArticleCancers2025
BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung Cancer.
Rebaz Ahmed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancers2025
Rebaz Ahmed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.